News
Market and company headlines
CLAll
Loading
BJ vs. CL: Which Stock Is the Better Value Option?
BJ vs. CL: Which Stock Is the Better Value Option?
09:00Yesterday1 Story
13:00Oct 241 Story
09:00-21:00Oct 232 Stories
Celsius vs. Colgate-Palmolive: Which Stock Should Investors Consider Before the Start of 2027?
One is a growth stock but faces Pepsi dependency; the other is a more mature company but has massive operating cash flow.
Colgate-Palmolive (CL) Earnings Expected to Grow: What to Know Ahead of Next Week's Release
Colgate-Palmolive (CL) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
11:00Oct 221 Story
11:00Oct 191 Story
08:00Oct 161 Story
08:00-10:00Oct 152 Stories
Own Colgate-Palmolive By Oct. 20 to Qualify for Its Nov. 13 Dividend. Here's How Many Shares You'd Need for $1,000 in Yearly Dividends.
Turn a five-figure investment into four-figure dividend income with this blue chip dividend growth stock.
What You Need to Know Ahead of Colgate-Palmolive Earnings Release
Colgate-Palmolive is set to release its third-quarter results soon, with analysts anticipating modest single-digit earnings growth.
15:00-17:00Oct 142 Stories
How Investors Are Reacting To Colgate-Palmolive (CL) Shifting Hill’s Toward Premium Branded Pet Nutrition
Recently, Colgate-Palmolive’s Hill’s pet nutrition business moved to replace discontinued retailer and private-label pet-food lines with its own higher-priced branded products, while management indicated it expects mid-single-digit Base Business EPS growth in 2026 supported by pricing and productivity amid higher advertising and input costs. This shift away from lower-margin private label production toward premium Hill’s offerings highlights how Colgate-Palmolive is reconfiguring its product...
Is Colgate-Palmolive (CL) Still A Bargain On Cash Flow?
Colgate-Palmolive has delivered a solid run over the past few years, which naturally raises a practical question for anyone looking at the stock today. Is the current share price of around US$89.95 still in line with the cash flows the business is expected to generate, or has sentiment pulled the market value away from what the underlying cash engine can support? Over the past 5 years, Colgate-Palmolive has returned 35.5%, which puts real money behind the question of how much of that...
14:00Oct 111 Story
10:00Oct 91 Story
18:00Oct 71 Story
04:00-06:00Oct 52 Stories
Wells Fargo Maintains Equal-Weight on Colgate-Palmolive, Lowers Price Target to $90
Wells Fargo analyst Chris Carey maintains Colgate-Palmolive (NYSE:CL) with a Equal-Weight and lowers the price target from $95 to $90.
Rising tensions in Yemen; Altman on AI - what’s moving markets
Investing.com - Futures linked to the main U.S. stock indices inch down, suggesting a cautious start to the trading week as investors assess the potential trajectory of Federal Reserve interest rates. Yemen’s Saudi-backed government launches an offensive against Iran-aligned Houthi militants controlling a key chokepoint for oil shipping, while Tehran vows not to reopen another nearby Gulf waterway until its conditions for a ceasefire with the U.S. are met. Yet indications that oil exports are co
08:00Oct 41 Story
10:00-18:00Sep 282 Stories
Colgate-Palmolive (CL) is Making Room for Its Stronger Growth Engines. Will it Pay Off?
As of September 11, Colgate-Palmolive Company (NYSE:CL) is exploring the potential sale of certain mass-market personal care brands, including Softsoap, Irish Spring, and Speed Stick, working alongside Goldman Sachs on the process, according to Reuters. The targeted divestments within its personal care unit could generate over $1 billion. This strategic review aligns with Colgate’s focus […]
EYE or CL: Which Is the Better Value Stock Right Now?
EYE vs. CL: Which Stock Is the Better Value Option?
02:00Sep 261 Story
10:00Sep 241 Story
10:00Sep 221 Story
10:00Sep 212 Stories
Is General Mills Positioned for a Beat in Q1 Earnings Release?
General Mills' innovation, premium offerings and broader distribution efforts are set to support brand relevance, engagement and first-quarter performance.
Does Long-Term Dividend Investing Really Work? This Study Says "Definitely."
Dividend growth stocks have outperformed other types and have done so with significantly less risk.
03:00-06:00Sep 212 Stories
Microsoft To Rally Over 23%? Here Are 10 Top Analyst Forecasts For Monday
Analysts raised targets for INSP, SECZ, CLF and WAT, while cutting targets for CRDO, CL and TTMI; ratings remained unchanged.
Piper Sandler Maintains Overweight on Colgate-Palmolive, Lowers Price Target to $95
Piper Sandler analyst Michael Lavery maintains Colgate-Palmolive (NYSE:CL) with a Overweight and lowers the price target from $98 to $95.
00:00Sep 201 Story
08:00Sep 181 Story
16:00-23:00Sep 172 Stories
Colgate’s Steady Dividend and Premium Push Might Change The Case For Investing In Colgate-Palmolive (CL)
Colgate-Palmolive’s board recently declared a quarterly cash dividend of US$0.53 per common share, payable on November 13, 2026, to shareholders of record on October 20, 2026, extending a dividend record that has remained uninterrupted since 1895. This reaffirmation of the dividend coincides with Colgate-Palmolive intensifying efforts to revive its North America business through greater support for premium toothpaste innovations and higher advertising investment. Next, we’ll consider how...
Colgate-Palmolive Declares Regular Quarterly Dividend
NEW YORK, September 17, 2026--The Board of Directors of Colgate-Palmolive Company (NYSE:CL) today declared a quarterly cash dividend of $0.53 per common share, payable on November 13, 2026, to shareholders of record on October 20, 2026. The Company has paid uninterrupted dividends on its common stock since 1895.
05:00-09:00Sep 172 Stories
One of These Dividend Kings Pays Out More Than It Earns. Which Dividend Is Safer?
Two Dividend Kings with 50-plus years of consecutive raises have reported earnings, and one of them is funding its payout in a way that should raise eyebrows. The question is whether that really makes it the riskier bet.
Colgate-Palmolive (CL) Lifts Ad Spend As Fair Value Debate Hangs On North America Recovery
Colgate-Palmolive (CL) is trying to fix a soft North America business after a tough second quarter by ramping support for premium toothpaste, lifting ad spend, and adjusting prices to compete more effectively. Recent trading reflects that mixed backdrop. The share price is US$87.02, with the 30 day share price return down 3.54% and the 90 day share price return down 2.75%. The year to date share price return is 12.01% and the 3 year total shareholder return is 26.57%, suggesting that longer...
10:00Sep 151 Story
10:00Sep 141 Story
09:00Sep 31 Story
15:00-20:00Sep 23 Stories
Colgate-Palmolive (CL) Draws Fresh Valuation Focus, Is The Stock Fully Priced?
Colgate-Palmolive (CL) is back in focus after fresh analysis highlighted its strong brand reach, premium pricing and free cash flow profile. At the same time, its forward P/E of 22.8x raises valuation questions. Colgate-Palmolive’s share price has climbed 15.97% year to date and 5.88% over the past 90 days. The 3-year total shareholder return of 33.66% suggests momentum has been building as investors weigh its cash generation and 22.8x forward P/E valuation. Compare Colgate-Palmolive’s...
3 Boring Stocks That Have Quietly Outlasted Every Bear Market of the Last 50 Years.
Three unglamorous companies have kept raising dividends through every bear market since the 1970s, and the reason they survived has nothing to do with innovation or hype.
11:00Sep 21 Story
11:00Aug 121 Story
13:00Aug 111 Story
13:00-23:00Aug 92 Stories
5 Revealing Analyst Questions From Colgate-Palmolive’s Q2 Earnings Call
Colgate-Palmolive’s second quarter results were met with a cautious market response, as the company’s revenue matched Wall Street’s expectations while non-GAAP profit modestly exceeded consensus. Management attributed the quarter’s performance to continued strength in emerging markets, particularly in India, Brazil, Mexico, and China, as well as resilience in the Hill’s pet nutrition business. However, operating margin contraction and flat sales volumes reflected persistent competitive pressures
What to Know About Colgate-Palmolive Director John Cahill Selling 4,170 Shares for $389,353
Cahill exercised stock options awarded in 2019, reducing his direct holdings by 13% while maintaining a $6.02 million total equity position.
